Mercelita, Egbus E.

HRN: 05-32-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2024
CEFUROXIME 500MG (TAB)
09/21/2024
09/27/2024
PO
500mg
BID
S/P NSVD WITH RMLE
Waiting Final Action 
09/22/2024
CEFUROXIME 1.5GM (VIAL)
09/22/2024
09/25/2024
IVT
1.5g
Q8 X 3 More Doses
UTI
Waiting Final Action 
09/24/2024
CEFUROXIME 1.5GM (VIAL)
09/24/2024
09/25/2024
IV
1.5 G
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: